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Summary
Background Eczema phenotypes and emotional and behavioural problems are
highly prevalent in childhood, but their mutual relationship is not fully clear.
Objectives To examine the associations of eczema phenotypes with school-age
emotional and behavioural problems, and the bidirectional associations of eczema
and emotional and behavioural problems from birth until 10 years.
Methods This study among 5265 individuals was embedded in a prospective pop-
ulation-based cohort study. Never, early transient, mid-transient, late transient
and persistent eczema phenotypes were identified based on parent-reported,
physician-diagnosed eczema from age 6 months until 10 years. Emotional (inter-
nalizing) and behavioural (externalizing) problems were measured repeatedly
using the Child Behavior Checklist from age 15 to 10 years. Cross-lagged models
were applied for bidirectional analyses.
Results All eczema phenotypes were associated with more internalizing problems
and attention problems at age 10 years, compared with never having eczema:
range of Z-score differences 014 [95% confidence interval (CI) 001–027] to
039 (95% CI 018–060). Children with early transient eczema had more
aggressive behaviour symptoms at age 10 years (Z = 016, 95% CI 005–027).
Bidirectional analysis showed that eczema at 0–2 years was associated with more
internalizing and externalizing problems at ages 3–6 and 10 years, while, inver-
sely, only internalizing problems at 0–2 years were associated with an increased
risk of eczema at age 10 years.
Conclusions Eczema phenotypes are very modestly associated with more somatic
symptoms and attention problems at school age. Early transient eczema is associ-
ated with more aggressive behaviour symptoms. Directional effects seem to occur
from early-life eczema to later-life internalizing and externalizing problems,
rather than the reverse.
What’s already known about this topic?
• Previous cohort studies using non-data-driven methods to define eczema pheno-
types observed that children with early-onset and persistent eczema had a higher
risk of emotional and behavioural problems in preadolescence.
• Alternatively, previous cohort studies showed that children with emotional and
behavioural problems had more severe eczema and eczema exacerbations in child-
hood.
• The direction of effects between eczema and emotional and behavioural problems
is not fully clear.
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What does this study add?
• Taking the variability of eczema onset and persistence within and between children
over time into account, all identified eczema phenotypes were very modestly asso-
ciated with more somatic symptoms and attention problems at school age.
• Directional effects seem to occur from eczema leading to emotional and beha-
vioural problems, rather than the reverse.
• Future research should focus on the effect of early optimal eczema management on
mental health disorders in children later in life.
Eczema is a common skin disorder in early life. Both genetic
and environmental early-life factors affect the risk of childhood
eczema.1,2 Psychopathological problems also seem to be
involved.3–5 We previously showed that maternal psychiatric
symptoms during pregnancy were associated with an increased
risk of childhood eczema, independently of maternal psychiatric
symptoms after birth or paternal psychiatric symptoms.6 Stress,
as a proxy of these problems, could shift the balance towards
type 2 T helper cells via the hypothalamic–pituitary–adrenal axis
and sympathetic adrenomedullary system, leading to more sus-
ceptibility to atopic diseases.7 It is not clear whether a child’s
emotional and behavioural problems affect the risk of eczema.
Previous systematic reviews and large survey studies showed
that children in all age groups with eczema had more emotional
problems, anxiety, depression, attention deficit hyperactivity dis-
orders and conduct disorders5,8–10 than children who never had
eczema. Taking the onset of eczema into account, it was shown
that children with early-onset, transient and chronic eczema had
increased risks of emotional and behavioural problems at age 10–
15 years.11,12 Alternatively, previous studies showed that children
with emotional and behavioural problems had more severe
eczema and eczema exacerbations at ages 3–18 years.3,4,9,10
Thus, the effects between eczema and emotional and behavioural
problems could be in both directions.9
Eczema phenotypes take into account the variability of
eczema onset and persistence within and between individuals
over time.13 Using eczema phenotypes might clarify which chil-
dren with eczema in early life are most at risk of emotional and
behavioural problems later in life. Additionally, bidirectional
analyses could reveal whether eczema leads to emotional and
behavioural problems or the reverse. Therefore, we aimed to
examine the associations of eczema phenotypes from birth until
age 10 years with school-age emotional and behavioural prob-
lems among 5265 individuals in a population-based prospective
cohort study. Next, we examined the associations of eczema
with emotional and behavioural problems from birth until age
10 years bidirectionally.
Patients and methods
Study design
This study was embedded in the Generation R Study, a popu-
lation-based prospective cohort study from early fetal life
onwards in Rotterdam, the Netherlands. Eligible women were
those who were living in Rotterdam and who had an expected
delivery date from April 2002 to January 2006, as described
previously.14 The children form a prenatally recruited birth
cohort that will be followed at least until young adulthood.
Around the age of 10 years, all children were invited to visit
our research centre in the Erasmus MC Sophia Children’s
Hospital to participate in hands-on measurements, advanced
imaging modalities, behavioural observations and biological
sample collection. The study was approved by the medical
ethical committee of the Erasmus MC, University Medical Cen-
ter Rotterdam, Rotterdam, the Netherlands. Written informed
consent was obtained from parents or legal guardians. For the
current analysis, children were included if they had available
information on eczema on at least three timepoints to create
eczema phenotypes, and any assessment of emotional and
behavioural problems from birth until the age of 10 years. In
total, 5265 children were included (Fig. S1; see Supporting
Information).
Eczema phenotypes
Information on physician-diagnosed eczema was obtained
from parental-reported questionnaires at the ages of 6 months
and 1, 2, 3, 4 and 10 years: ‘Was your child diagnosed with
eczema in the last 6 months/last year by a general practitioner
or physician in the hospital?’ (no; yes). In children with avail-
able data on physician-diagnosed eczema on at least three
timepoints, we previously identified five eczema phenotypes,
namely never, early transient, mid-transient, late transient and
persistent eczema.13 The children were assigned to the eczema
phenotype for which they had the highest posterior probabil-
ity. Data on ever having eczema were collected by parent-
reported questionnaires at 10 years of age: ‘Has your child
ever had eczema diagnosed by a doctor?’.
Emotional and behavioural problems
The Child Behavior Checklist (CBCL) was used to assess parent-
reported child emotional and behavioural problems. This
instrument has proven to be reliable and valid in various popu-
lation samples from different countries and cultures.15,16 The
symptoms were measured at median (interquartile range) ages
of 15 (15–16), 30 (30–31), 60 (58–62) and 97
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(96–98) years. At the ages of 15, 3 and 6 years, the pre-
school CBCL version for children aged 15–5 years (CBCL/15–
5) was used.17 At the age of 10 years, the school-age version
of the CBCL for children aged 6–18 years was used (CBCL/6–
18).
The CBCL consists of empirically derived broadband scales
and syndrome scales. We used two broadband scales and five
syndrome scales based on the strongest associations with
eczema observed in previous studies.3–5,8–12 We examined the
broadband scale of internalizing problems, a measure of emo-
tional problems, and the three comprising syndrome scales of
anxious-depressed, withdrawn-depressed and somatic symp-
toms (e.g. constipation, dizziness, headaches). We also exam-
ined the broadband scale externalizing problems, a measure of
behavioural problems, and the two comprising syndrome
scales of attention problems and aggressive behaviour symp-
toms at ages 15, 3 and 5 years, and only aggressive behaviour
symptoms at age 10 years. In CBCL/6–18, attention problems
are not part of externalizing problems due to their sizeable
factor in both broadband scales in factor analysis.15 Scale
scores were log, quadratic and square-root transformed and
then standardized because of non-normal distributions.
Covariates
Information on maternal age, parity (multiparous; nulliparous),
education (primary or secondary school; higher than secondary
school) and parental history eczema, allergy or asthma (no;
yes) was available from questionnaires obtained at enrolment.
Maternal psychiatric symptoms during pregnancy were defined
using the Global Severity Index.18 The child’s sex, gestational
age at birth and birthweight were obtained from midwives and
hospital records, and ethnic origin (European; non-European)
was defined based on the parents’ country of birth according to
Statistics Netherlands.19 Postnatal questionnaires provided infor-
mation on breastfeeding at 2, 6 and 12 months after birth,
which was combined into never vs. ever, and on sleep prob-
lems at 2 months after birth (no; yes).
Statistical analysis
We compared the characteristics of those included and not
included in our study using Pearson’s v2-test, an independent-
samples t-test and the Mann–Whitney U-test. We examined
the associations of eczema phenotypes with internalizing and
externalizing problems, and comprising syndrome scales, at
age 10 years using linear regression models. Next, cross-
lagged models were used to examine bidirectional associations
of eczema with internalizing and externalizing problems, and
comprising syndrome scales, from birth until 10 years. Cross-
lagged models allow associations between two repeatedly
measured variables to be examined in both directions simulta-
neously while accounting for continuity between the repeated
measures over time. With this method, we were able to disen-
tangle the predominant direction of the observed association
between eczema and emotional and behavioural problems.
In order to make a more balanced model, three age categories
(0–2, 3–6 and 10 years) were defined based on the prevalence
of physician-diagnosed eczema and distribution of CBCL scales.
We examined cross-lagged effects, cross-sectional effects and sta-
bility effects. A conceptual model of the studied cross-lagged
associations is presented in Figure S2 (see Supporting Informa-
tion). Bidirectional associations of withdrawn-depressed symp-
toms were not studied because this scale was not assessed by
CBCL/15–5. All analyses were adjusted for potential con-
founders, which were selected from the literature based on
whether they were strongly related to eczema and internalizing
and externalizing problems, and were not in the causal pathway.
Therefore maternal age; parity; history of eczema, allergy or
asthma; and child’s birthweight were not included in the model.
We assumed that data were missing at random. The amount of
missing data in covariates was ≤ 21%, and 125 datasets were
created using multiple imputation by chained equations.
The class assignment was sampled using the participant-spe-
cific posterior class probabilities determined by the latent class
growth model in regression modelling based on the posterior
probabilities, in order to take into account the uncertainty of
eczema phenotype class assignment. The size and direction of
the effect estimates were similar when we used complete-case
analyses, and therefore we present only the results based on
imputed data. For more easy interpretation, we also examined
the associations of eczema phenotypes with borderline clinical
cutoffs of the internalizing and the externalizing problem
scales (< 84th vs. ≥ 84th percentile) and syndrome scales
(< 80th vs. ≥ 80th percentile).15
All research questions, including defined exposure defini-
tions and outcomes, and statistical analyses, were determined
a priori, discussed with the principal investigators and study
team members, and adapted where appropriate. No post hoc
analyses were performed. We did not adjust for multiple test-
ing, because the used syndrome scales were related to each
other and examined under the same hypothesis. All measures
of association are presented as Z-score differences or odds
ratios (ORs), together with their corresponding 95% confi-
dence intervals (CIs). Imputation and regression analyses were
performed using the packages ‘mice’ (version 330) and
‘stats’ (version 352) in R version 352,20,21 and cross-lagged
analyses were performed in Mplus version 82.22
Results
Characteristics of the cohort
The characteristics of the children and their mothers are
shown in Table 1. Rates of physician-diagnosed eczema ran-
ged from 16% at age 6 months to 6% at age 10 years, and
23% of children had ever had eczema at age 10 years. Com-
pared with children who were included in the analysis, those
not included had mothers who had lower education and more
often had psychiatric symptoms and a history of asthma,
allergy or eczema (Table S1; see Supporting Information).
Children not included were more often of non-European
© 2019 The Authors. British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists
British Journal of Dermatology (2019)
Eczema phenotypes and emotional and behavioural problems, C. Hu et al. 3
ethnicity and never breastfed, and had a lower gestational age
and birthweight.
Eczema phenotypes and internalizing problems in
school-age children
Compared with children who had never had eczema, those
who had ever had eczema had more internalizing problems,
including more anxious-depressed and somatic symptoms at
age 10 years – Z-score differences (95% CI) 021 (014–
029), 010 (002–017) and 029 (022–037), respectively
(Table 2) – but not withdrawn-depressed symptoms. Com-
pared with the never eczema phenotype, all eczema pheno-
types were associated with more internalizing problems
[range 014 (95% CI 001–027) to 030 (95% CI 010–
051)] and an increased risk of somatic symptoms [range
013 (95% CI 001–024) to 039 (95% CI 018–060)].
When we used borderline clinical cutoffs, children with early
Table 1 Characteristics of the children and their mothers
All patients (N = 5265)
Never eczema phenotype
(n = 3995)
Ever eczema phenotypea
(n = 1270)
Maternal characteristics
Age at enrolment (years), mean  SD 315  46 315  46 314  46
Parity, nulliparous, n (%) 3072 (58) 2280 (57) 792 (62)
Maternal education, higher, n (%) 3001 (57) 2277 (57) 724 (57)
Maternal psychiatric symptom scale, median (IQR) 01 (01–03) 01 (01–03) 02 (01–03)
Child characteristics
Sex, female, n (%) 2652 (50) 2041 (51) 611 (48)
Gestational age at birth (weeks), median (IQR) 401 (390–410) 401 (390–410) 401 (390–410)
Birthweight (g), mean  SD 3446  567 3454  569 3422  559
Ethnicity, non-European, n (%) 1331 (25) 984 (25) 347 (27)
Breastfeeding, ever, n (%) 4857 (92) 3695 (93) 1162 (92)
Sleep problems at 2 months, yes, n (%) 615 (12) 447 (11) 168 (13)
Eczema phenotypes, n (%)b
Never 3995 (76) 3995 (100) 0
Early transient 434 (8) 0 434 (34)
Mid-transient 302 (6) 0 302 (24)
Late transient 412 (8) 0 412 (32)
Persistent 122 (2) 0 122 (10)
Emotional and behavioural problems at age 10 years, median item score (IQR)b
Internalizing problems 3 (1–7) 3 (1–6) 4 (2–7)
Anxious-depressed symptoms 1 (0–3) 1 (0–3) 1 (0–3)
Withdrawn-depressed symptoms 1 (0–2) 0 (0–2) 1 (0–2)
Somatic symptoms 1 (0–2) 1 (0–2) 1 (0–2)
Externalizing problems 2 (0–5) 2 (0–5) 3 (1–6)
Aggressive behaviour symptoms 2 (0–4) 1 (0–4) 2 (0–5)
Attention problems 2 (1–5) 2 (1–5) 3 (1–6)
Values are presented after imputation. aEver eczema phenotype consists of early transient, mid-transient, late transient and persistent eczema
phenotypes. bData were not imputed, and were missing for ever/never eczema at age 10 years (29%), and emotional and behavioural prob-
lems at age 15 (12%), 3 (12%), 6 (13%) and 10 years (26%).
Table 2 Associations of eczema phenotypes with internalizing problems at age 10 years
Internalizing problems Anxious-depressed symptoms Withdrawn-depressed symptoms Somatic symptoms
Never Reference Reference Reference Reference
Ever 021 (014–029)* 010 (002–017)* 005 (002–012) 029 (022–037)*
Never Reference Reference Reference Reference
Early transient 020 (009–031)* 010 (002–021) 009 (002–020) 023 (012–034)*
Mid-transient 014 (001–027)* 012 (001–025) 012 (001–025) 015 (002–027)*
Late transient 014 (003–025)* 007 (004–019) 009 (003–020) 013 (001–024)*
Persistent 030 (010–051)* 018 (003–038) 000 (020–021) 039 (018–060)*
Values are average standardized regression coefficients (Z-scores) (95% confidence intervals) from linear regression models. The reference
group is the never eczema (phenotype) group. Models were adjusted for maternal education and psychiatric symptoms, and child’s sex, ges-
tational age, ethnicity, breastfeeding and sleep disturbances. *P < 005.
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transient, late transient and persistent eczema had the highest
risks of somatic symptoms at age 10 years: ORs 161 (95% CI
126–204), 143 (95% CI 112–183) and 237 (95% CI
153–366), respectively (Table S2; see Supporting
Information).
Eczema phenotypes and externalizing or attention
problems in school-age children
Compared with children who had never had eczema, those
who had ever had eczema had more externalizing problems,
including more symptoms of aggressive behaviour, and atten-
tion problems: Z-score differences (95% CI) 013 (006–021),
012 (005–019) and 015 (008–023), respectively
(Table 3). Compared with the never eczema phenotype, only
early transient eczema was associated with more externalizing
problems, including more symptoms of aggressive behaviour:
Z-scores 016 (95% CI 004–027) and 016 (95% CI 005–
027). All eczema phenotypes were associated with more atten-
tion problems: Z-score range 015 (95% CI 004–026) to 024
(95% CI 004–045). When we used borderline clinical cutoffs,
children with early transient, mid-transient and persistent
eczema had the highest risks of attention problems: OR range
136 (95% CI 102–181) to 174 (95% CI 108–279)
(Table S3; see Supporting Information).
Direction of associations between eczema and emotional
and behavioural problems
Figure 1 and Table S4 (see Supporting Information) show the
bidirectional associations between eczema and internalizing
problems. Cross-lagged effects showed that compared with
children without eczema at ages 0–2 years, those with eczema
at ages 0–2 years had more internalizing problems at ages 3–6
years and 10 years: Z-score differences 008 (95% CI 002–
015) and 009 (95% CI 002–016) (Fig. 1a). This included
more anxious-depressed symptoms at ages 3–6 years (Z-score
difference 008, 95% CI 002–015) (Fig. 1b) and more
somatic symptoms at ages 3–6 years and 10 years (Z-score dif-
ferences 011, 95% CI 004–018, and 013, 95% CI 005–
020) (Fig. 1c). Reversely, cross-lagged effects showed that
children with more internalizing problems at ages 0–2 years
had an increased risk of eczema only at age 10 years: OR 119
(95% CI 100–140) per point increase in internalizing prob-
lem scale) (Fig. 1a). No associations of anxious-depressed or
somatic symptoms with later eczema were observed (Fig. 1b,
c).
Figure 2 and Table S4 (see Supporting Information) show
the bidirectional associations between eczema and externalizing
problems. Cross-lagged effects showed that compared with
children without eczema at ages 0–2 years, children with
eczema at ages 0–2 years had more externalizing problems at
age 10 years only (Z-score difference 008, 95% CI 001–014)
(Fig. 2a), including more aggressive behaviour at age 10 years
(Z-score difference 008, 95% CI 001–014) (Fig. 2b). Com-
pared with children without eczema at ages 0–2 and 3–6 years,
children with eczema in those age groups had more attention
problems at age 10 years [Z-score differences 009 (95% CI
002–015) and 010 (95% CI 001–019), respectively]
(Fig. 2c). Reversely, no associations of early externalizing prob-
lems or the related syndrome scales with later eczema were
observed (Fig. 2). The full results of the cross-sectional and sta-
bility effects of eczema with internalizing and externalizing
problems are presented in Table S4 (see Supporting Informa-
tion).
Discussion
In this population-based prospective cohort study, we
observed that children who had ever had eczema had more
emotional (internalizing) and behavioural (externalizing)
problems at the age of 10 years than children without eczema.
All eczema phenotypes were consistently but very modestly
associated with more somatic symptoms and attention prob-
lems at school age. Additionally, children with early transient
eczema had more aggressive behaviour symptoms at school
age. The directions of effects were predominantly present for
eczema until 2 years leading to increased internalizing and
externalizing problems at school age rather than the reverse.
We observed that children who had ever had eczema had
more internalizing and externalizing problems at school age.
These results are in line with previous meta-analyses.3–5,10
Table 3 Associations of eczema phenotypes with externalizing problems at age 10 years
Externalizing problems Aggressive behaviour symptoms Attention problems
Never Reference Reference Reference
Ever 013 (006–021)* 012 (005–019)* 015 (008–023)*
Never Reference Reference Reference
Early transient 016 (004–027)* 016 (005–027)* 020 (009–031)*
Mid-transient 012 (001–025) 012 (001–025) 021 (008–034)*
Late transient 008 (003–020) 010 (001–022) 015 (004–026)*
Persistent 005 (016–026) 004 (017–024) 024 (004–045)*
Values are average standardized regression coefficients (Z-scores) (95% confidence intervals) from linear regression models. The reference
group is the never eczema (phenotype) group. Models were adjusted for maternal education and psychiatric symptoms, and child’s sex, ges-
tational age, ethnicity, breastfeeding and sleep disturbances. *P < 005.
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Concerning the internalizing problems, we observed that chil-
dren who had ever had eczema had more anxious-depressed
symptoms only, but not when we grouped children based on
the onset and persistence over time using data-driven analysis.
In contrast, previous meta-analyses showed that children with
eczema had more anxious and depressed symptoms.4,5 The dif-
ferences in results might partly be explained by our study popu-
lation, which consists of relatively healthy and young children
until age 10 years, compared with previous studies consisting of
patients and children until 18 years. Those studies observed
(a)
(b)
(c)
Fig 1. Bidirectional associations between eczema and internalizing problems. Directions of associations between physician-diagnosed eczema and
(a) internalizing problems, (b) anxious-depressed symptoms and (c) somatic symptom from birth until age 10 years. The arrows indicate the
directions of the associations. Values are average standardized regression coefficients for internalizing problems as the outcome, and odds ratios for
eczema as the outcome (reference group: no eczema) derived from linear or logistic regression models, using cross-lagged modelling. Models
were adjusted for maternal education and psychiatric symptoms, and child’s sex, gestational age, ethnicity, breastfeeding and sleep disturbances.
*P < 005. The corresponding 95% confidence intervals of the cross-lagged effects, and the effect estimates of the cross-sectional and stability
effects are shown in Table S4 (see Supporting Information).
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stronger effect estimates of eczema with anxious and depressed
symptoms in adults compared with children.4 Also, differences
in sample size, definition of eczema and measurement tools for
anxiety- and depression-related symptoms might have played a
role.
Furthermore, we observed that all eczema phenotypes
were most consistently associated with more somatic symp-
toms and attention problems at school age. Previous cohort
studies using non-data-driven methods to define eczema
phenotypes, such as grouping of children by researchers’
(a)
(b)
(c)
Fig 2. Bidirectional association between eczema and externalizing problems. Direction of associations between physician-diagnosed eczema and
(a) externalizing problems, (b) aggressive behaviour symptoms and (c) attention problems from birth until age 10 years. The arrows indicate the
directions of the associations. Values are average standardized regression coefficients for externalizing problems as the outcome and odds ratios for
eczema as the outcome (reference group: no eczema) derived from linear or logistic regression models, using cross-lagged modelling. Models
were adjusted for maternal education and psychiatric symptoms, and child’s sex, gestational age, ethnicity, breastfeeding and sleep disturbances.
*P < 005. The corresponding 95% confidence intervals of the cross-lagged effects, and the effect estimates of the cross-sectional and stability
effects are shown in Table S4 (see Supporting Information).
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experiences, observed that children with early-onset and
persistent eczema had a higher risk of emotional and beha-
vioural problems in preadolescence.4,9–11 While data-driven
analyses appear to be less biased, the best method to define
eczema phenotypes depends on the study population, data
distribution and availability, and specific research aim.
To the best of our knowledge, our study is the first to apply
cross-lagged modelling for bidirectional analyses, and we
observed that eczema until age 2 years was associated with
more emotional and behavioural problems at school age more
dominantly than reversely. These findings contribute to the
disentanglement of the complex bidirectional relationship of
eczema with emotional and behavioural problems and suggest
that the directional effects are from early-life eczema to later-
life internalizing and externalizing problems rather than the
reverse.
The modest effect sizes of the observed associations of
eczema phenotypes with emotional and behavioural problems
imply that, on a population-based level, most children with
eczema are mentally healthy. However, the results might be
different on an individual or hospital-based level. When we
used subclinical cutoffs, the effect estimates were greater and
consistent for the association of early transient eczema with
the risk of emotional and behavioural problems. Therefore,
part of our results are in line with the current European
guidelines, suggesting that children with moderate or recur-
rent eczema should receive psychosomatic counselling.23
Future studies are needed to examine the role of such eczema
treatment on the development of emotional and behavioural
problems later in life, while taking severity and genetic sus-
ceptibility into account.
Several hypotheses exist on the relationship of eczema with
emotional and behavioural problems. Eczema and related
symptoms such as chronic itchiness, red patchy skin appear-
ance and disturbed sleep could negatively affect mental health
via social isolation, low self-image, lack of concentration and
more irritability, and possibly also via low-grade inflammation
and blood–brain barrier disruption.10,24–26 Conversely, stress,
as a proxy of these problems, could shift the balance towards
type 2 T helper cells via the hypothalamic–pituitary–adrenal
axis and sympathetic adrenomedullary system, leading to more
susceptibility to atopic inflammation and diseases, resulting in
a vicious cycle.7
Another explanation is based on shared pathogenesis
between eczema and mental health disorders, as both skin
cells and neurons originate from the ectoderm.27 Shared
common genetic variants were found for skin barrier defects
and mental health disorders that are involved in both his-
tamine and immune response regulation, and the dopaminer-
gic system.28–32 The immune system has been associated
with many mental health disorders in adults, but the under-
lying pathways remain unclear.33 Expression of proinflamma-
tory factors in adults with atopic diseases and autism
spectrum disorders was shown to disrupt the blood–brain
barrier.34 Therefore, chronic inflammation, specifically in
early life when maturation of the nervous system and the
immune system is still ongoing, might increase susceptibility
for mental health disorders.
The strengths of this study are its prospective design with
detailed, repeated information on eczema and emotional
and behavioural problems, and the use of data-driven
defined eczema phenotypes. By using sampling based on
class assignment probabilities, we achieved less misclassifica-
tion bias and more precise effect estimates. However, some
methodological limitations need to be addressed. The exclu-
sion of some children resulted in a selection towards a
healthier and more affluent population. Secondly, reporting
of emotional and behavioural problems by parents of chil-
dren with eczema might be different from that by parents
of children without eczema. We tried to minimize this mis-
classification by using validated questionnaires.15,35 Thirdly,
residual confounding might be present as not all factors
associated with eczema and emotional and behavioural
problems were measured or included in the analysis, such
as severity of eczema, sleep problems in later life, and other
(atopic) comorbidities.10 No information was available to
determine the severity of cases of eczema. Fourthly, the
clinical impact might be minimal due to the observed very
modest effect sizes in Z-score differences and the use of sub-
clinical cutoffs for the associations of eczema phenotypes
with emotional and behavioural problems in this popula-
tion-based study. Lastly, we cannot exclude that the obser-
vations from cross-lagged models might be the result of the
natural course of the studied conditions.2,36 However, cross-
lagged models take the natural course into account by
adjusting for the stability effects.
In conclusion, all eczema phenotypes were very modestly
associated with more somatic symptoms and attention prob-
lems at school age. Children with early transient eczema had
more symptoms of aggressive behaviour. The very modest
effect sizes of the observed associations of eczema pheno-
types with emotional and behavioural problems imply that,
on a population-based level, most children with eczema are
mentally healthy. The directional effects occur from eczema
in early life leading to internalizing and externalizing prob-
lems in later life, rather than the reverse. Therefore, future
research should focus on the effect of early optimal eczema
management on mental health disorders in children later in
life.
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